Nxstage Medical (NXTM) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	60.82M
Accounts receivable, net	30.58M
Inventory	46.88M
Prepaid expenses and other current assets	5.88M
Total current assets	144.15M
Property and equipment, net	65M
Field equipment, net
Deferred cost of revenues
Intangible assets, net
Goodwill	42.71M
Other assets	2.62M
Total assets	319.11M
Accounts payable	14.76M
Accrued expenses	29.34M
Current portion of long-term debt	330K
Total current liabilities	48.53M
Deferred revenues	50.97M
Long-term debt	1.45M
Other long-term liabilities	16.83M
Total liabilities	117.77M
Commitments and contingencies (Note 10)	0
Undesignated preferred stock: par value $0.001, 5,000,000 shares authorized; no shares issued and outstanding as of June 30, 2011 and December 31, 2010	0
Common stock: par value $0.001, 100,000,000 shares authorized; 55,172,136 and 54,043,317 shares issued as of June 30, 2011 and December 31, 2010, respectively	65K
Additional paid-in capital	626.04M
Accumulated deficit	-406M
Accumulated other comprehensive income	-4.33M
Treasury stock, at cost: 480,923 and 325,104 shares as of June 30, 2011 and December 31, 2010, respectively	-15.83M
Total stockholders' equity	199.95M
Total liabilities and stockholders' equity	319.11M

Entities mentioned with NXTM

View All Entities